Company Tagline
Developing life enhancing treatments for chronic respiratory diseases
Industry Category
Business Keywords
Company Description
Verona Pharma is a dynamic biopharmaceutical company dedicated to the development and commercialization of innovative therapies aimed at treating chronic respiratory diseases, addressing significant unmet medical needs in this critical area. Verona Pharma is committed to enhancing the lives of patients through groundbreaking research and development.
With a focus on pioneering treatments, Verona Pharma's lead product candidate, ensifentrine, holds the potential to revolutionize respiratory disease management by combining bronchodilator and anti-inflammatory activities into a single compound. The company's commitment to scientific excellence and patient-centric innovation drives its mission to improve respiratory health outcomes. Verona Pharma's headquarters are located at 3 More London Riverside, London, UK SE1 2RE, GB, with additional offices at 8045 Arco Corporate Drive, Suite 130, Raleigh, North Carolina 27617, US and 33 Park of Commerce Way, Savannah, Georgia 31405, US.
Listed on the Nasdaq Global Market under the ticker symbol VRNA, Verona Pharma continues to advance its research and development programs, striving to make a meaningful impact on the lives of individuals affected by chronic respiratory conditions. We invite the management team at Verona Pharma to enhance your company's visibility by creating a customized and exclusive company showcase and product listing on our platform, further amplifying your reach and engagement within the industry.
Verona Pharma est une entreprise biopharmaceutique dynamique dédiée au développement et à la commercialisation de thérapies innovantes visant à traiter les maladies respiratoires chroniques, répondant ainsi aux besoins médicaux importants non satisfaits dans ce domaine crucial. Verona Pharma s'engage à améliorer la vie des patients grâce à une recherche et un développement novateurs.
En mettant l'accent sur les traitements pionniers, le principal produit candidat de Verona Pharma, l'ensifentrine, a le potentiel de révolutionner la gestion des maladies respiratoires en combinant les activités bronchodilatatrices et anti-inflammatoires en un seul composé. L'engagement de l'entreprise envers l'excellence scientifique et l'innovation centrée sur le patient motive sa mission d'améliorer les résultats en matière de santé respiratoire. Le siège social de Verona Pharma est situé au 3 More London Riverside, Londres, UK SE1 2RE, GB, avec des bureaux supplémentaires au 8045 Arco Corporate Drive, Suite 130, Raleigh, Caroline du Nord 27617, US et au 33 Park of Commerce Way, Savannah, Géorgie 31405, US.
Cotée sur le Nasdaq Global Market sous le symbole boursier VRNA, Verona Pharma continue de faire progresser ses programmes de recherche et développement, s'efforçant d'avoir un impact significatif sur la vie des personnes touchées par des affections respiratoires chroniques. Nous invitons l'équipe de direction de Verona Pharma à améliorer la visibilité de votre entreprise en créant une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme, amplifiant ainsi votre portée et votre engagement au sein de l'industrie.
Key Personnel / Employees
Compare Companies Side by Side
Compare Verona Pharma with 3 companies in Biotechnology-Research
| Comparison Field |
Ve
Verona PharmaMain Company |
MGC DiagnosticsView Profile |
Manitoba Lung Associ...View Profile |
NEMERAView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1977 | 1904 | |
|
Company Size
|
— | 201-500 | 2-10 | 1,001-5,000 |
|
City
|
London, UK | St. Paul, MN | Winnipeg, Manitoba | Lyon, Auvergne-Rhône-Alpes |
|
Country
|
United Kingdom | United States | Canada | |
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Biopharmaceutical
Respiratory Diseases
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Drug Development
Clinical Trials
Pharmaceutical Innovation
Novel therapies for chronic respiratory diseases
CF
COPD
|
8 Total
8 Unique
Unique Skills:
CardioRespiratory Diagnostic Products
CardioRespiratory Diagnostic Seminar
Centralized Respiratory Clinical Trial Services
Gas Exchange
Health Information Exchange Providor
Indirect Calorimetry
+2
|
10 Total
10 Unique
Unique Skills:
advocacy
air quality
Bronchitis
Health
Long Covid-19
Lung Cancer
+4
|
29 Total
29 Unique
Unique Skills:
Airless dispensers
Allergic rhinitis
Autoinjectors
Dermal
Design
Diabetes
+23
|
4
Total Companies1904
Oldest Founded3
Countries57
Unique SkillsSimilar Companies
Other organizations in the same industry
Myriad Genetics
Biotechnology-ResearchWe're a leading genetic testing and precision medicine company dedicated to advancing health and wel...
Alternative Company Names
This company is also known as